MetaMedical™ Solutions Inc

price change in recent years

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Hardy Diagnostics apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

Hardy Diagnostics overview

Hardy Diagnostics (Hardy) is a medical device manufacturing company. It offers various products such as clinical diagnostics, general laboratory supplies, food safety testing, pharmaceutical and compounding pharmacy, cannabis quality assurance testing, inoculation supplies, cosmetics testing and featured products. The company’s general laboratory equipment includes labels, liquid handling, inoculation supplies, temperature monitoring, personal protective equipment, susceptibility disks, and cleaning and microscope supply equipment. Its services include product evaluations and regulatory submissions, instrument services and custom product distribution. The company’s brands include AnaeroGRO, NG-Test, HardyCHROM, TRIO.BAS, Pathfinder and CompactDry, among others. It distributes its products across the US. Hardy is headquartered in Santa Maria, California, the US.

For a complete picture of STREPPRO, Respiratory Disease Tests pricing in the US, buy the report here.

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.

Source link